Citations to this article


Mice deleted for the plasminogen activator inhibitor-1 (PAI-1) gene are relatively protected from developing pulmonary fibrosis induced by bleomycin. We hypothesized that PAI-1 deficiency reduces fibrosis by promoting plasminogen activation and accelerating the clearance of fibrin matrices that accumulate within the damaged lung. In support of this hypothesis, we found that the lungs of PAI-1–/– mice accumulated less fibrin after injury than wild-type mice, due in part to enhanced fibrinolytic activity. To further substantiate the importance of fibrin removal as the mechanism by which PAI-1 deficiency limited bleomycin-induced fibrosis, bleomycin was administered to mice deficient in the gene for the Aα-chain of fibrinogen (fib). Contrary to our expectation, fib–/– mice developed pulmonary fibrosis to a degree similar to fib+/– littermate controls, which have a plasma fibrinogen level that is 70% of that of wild-type mice. Although elimination of fibrin from the lung was not in itself protective, the beneficial effect of PAI-1 deficiency was still associated with proteolytic activity of the plasminogen activation system. In particular, inhibition of plasmin activation and/or activity by tranexamic acid reversed both the accelerated fibrin clearance and the protective effect of PAI-1 deficiency. We conclude that protection from fibrosis by PAI-1 deficiency is dependent upon increased proteolytic activity of the plasminogen activation system; however, complete removal of fibrin is not sufficient to protect the lung.


Noboru Hattori ... Richard H. Simon, Angela F. Drew


Total citations by year

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 Total
Citations: 3 5 6 12 12 5 5 14 4 10 10 8 11 3 2 1 111
Citation information

Citations to this article in year 2008 (14)

Title and authors Publication Year
Advances in mechanisms of repair and remodelling in acute lung injury
CC Dos Santos
Intensive Care Medicine 2008
Oxidative Stress, Plasminogen Activator Inhibitor 1, and Lung Fibrosis
RM Liu
Antioxidants & Redox Signaling 2008
The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy
M Gharaee-Kermani, B Hu, SH Phan, MR Gyetko
Expert Opinion on Investigational Drugs 2008
New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury
GE Arteel
Journal of Gastroenterology and Hepatology 2008
Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury
GB Allen, ME Cloutier, YC Larrabee, K Tetenev, ST Smiley, JH Bates
American journal of physiology. Lung cellular and molecular physiology 2008
Urokinase and its receptors in chronic kidney disease
G Zhang, AA Eddy
Frontiers in bioscience : a journal and virtual library 2008
Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy
F Milliat, JC Sabourin, G Tarlet, V Holler, E Deutsch, V Buard, R Tamarat, A Atfi, M Benderitter, A François
The American Journal of Pathology 2008
Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis
PF Mercer, RH Johns, CJ Scotton, MA Krupiczojc, M Königshoff, DC Howell, RJ McAnulty, A Das, AJ Thorley, TD Tetley, O Eickelberg, RC Chambers
American journal of respiratory and critical care medicine 2008
The Absence of uPAR Is Associated with the Progression of Dermal Fibrosis
Y Kanno, A Kaneiwa, M Minamida, M Kanno, K Tomogane, K Takeuchi, K Okada, S Ueshima, O Matsuo, H Matsuno
Journal of Investigative Dermatology 2008
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy
P Pontrelli, M Rossini, B Infante, G Stallone, A Schena, A Loverre, M Ursi, R Verrienti, A Maiorano, G Zaza, E Ranieri, L Gesualdo, P Ditonno, C Bettocchi, FP Schena, G Grandaliano
Transplantation 2008
Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients
K Kowal, S Żukowski, M Moniuszko, A Bodzenta-Łukaszyk
Folia Histochemica et Cytobiologica 2008
Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis
T Nakashima, A Yokoyama, Y Onari, H Shoda, Y Haruta, N Hattori, T Naka, N Kohno
Journal of Allergy and Clinical Immunology 2008
The Role of Inflammation in the Pathogenesis of Idiopathic Pulmonary Fibrosis
BD Bringardner, CP Baran, TD Eubank, CB Marsh
Antioxidants & Redox Signaling 2008
Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?
RC Chambers
British Journal of Pharmacology 2008